Pantilag, Jerric Renz S.
HRN: 19-82-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
CEFUROXIME 750MG (VIAL)
05/16/2022
05/22/2022
IVT
265
Q8 For 7 Days
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes